Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Pierre Fabre Pharma Norden AB

Closing information (x1000 SEK)

Closing information 2024/12 2023/12 2022/12
Turnover 240,572 Less Arrow 208,091 More Arrow 242,913
Financial expenses 163 More Arrow 345 More Arrow 581
Earnings before taxes 8,574 Less Arrow 6,359 More Arrow 8,056
EBITDA 7,785 Less Arrow 6,078 More Arrow 8,857
Total assets 186,951 Less Arrow 156,766 Less Arrow 130,312
Current assets 186,097 Less Arrow 155,859 Less Arrow 129,384
Current liabilities 155,908 Less Arrow 132,579 Less Arrow 105,053
Equity capital 31,043 Less Arrow 24,187 More Arrow 25,259
- share capital 400 Equal arrow 400 Equal arrow 400
Employees (average) 13 More Arrow 16 Less Arrow 15

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 16.6% Less Arrow 15.4% More Arrow 19.4%
Turnover per employee 18,506 Less Arrow 13,006 More Arrow 16,194
Profit as a percentage of turnover 3.6% Less Arrow 3.1% More Arrow 3.3%
Return on assets (ROA) 4.7% Less Arrow 4.3% More Arrow 6.6%
Current ratio 119.4% Less Arrow 117.6% More Arrow 123.2%
Return on equity (ROE) 27.6% Less Arrow 26.3% More Arrow 31.9%
Change turnover 32,481 Less Arrow -34,822 More Arrow 35,106
Change turnover % 16% Less Arrow -14% More Arrow 17%
Chg. No. of employees -3 More Arrow 1 Equal arrow 1
Chg. No. of employees % -19% More Arrow 7% Equal arrow 7%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.